Nailii Successfully Delivers Local New Crown Vaccine Line in Turkey
Shanghai Nailii helped Turkey to successfully complete the production line of Neocrown vaccine, as the largest domestic production line of Neocrown vaccine in Turkey, its production Turkovac has been approved for use.
On December 22, 2021, Turkish Health Minister Koca announced that Turkey's locally produced Neocrown vaccine, Turkovac, has been approved for emergency use. He stated that Turkey has become one of nine countries producing COVID-19 vaccine and announced that Turkovac will be widely used.
Turkey is now one of nine countries in the world to develop its own vaccine," Akdo?an told Anadolu Agency. This is a historic achievement, both for us in the field of biotechnology and for the progress in the field of new coronavirus vaccines. Turkovac will be at the forefront in this field to develop other vaccines and biotechnology products and their production. Developing our own biomedical products, from drugs to vaccines, is a strategic issue. Just as it is important to cut off dependence on the defense industry, it is also important to be scientifically advanced enough to develop its own medical products. In that sense, Turkovac is a turning point for us."